Biooutsource Limited, Glasgow

Write review
updated on 20/06/2020

Opening Times

Hours may differ
FridayFr
09:00 – 16:00
SaturdaySaClosed
SundaySuClosed
MondayMo
09:00 – 17:00
TuesdayTu
09:00 – 17:00
WednesdayWe
09:00 – 17:00
ThursdayTh
09:00 – 17:00
Closed.
Opens in  2 days 9 h 52 min.
2 days 9 h 52 min

Official Data

Official Name
SARTORIUS STEDIM BIOOUTSOURCE LIMITED
Reg. office address
1 TECHNOLOGY TERRACE ACRE ROAD, TODD CAMPUS, WEST OF SCOTLAND SCIENCE PARK, G20 0XA, GLASGOW, Glasgow City
Company Number
SC319460
Jurisdiction
Scotland
SIC Code
74909 - Other professional, scientific and technical activities n.e.c.
Date of Incorporation
26 Mar 2007
Company Type
Private Limited Company

Description

BioOutsourcing lab - Leader in contract Vaccine and microbiological testing that provides lot release virus, vaccine and biosimilars tests.


Company description
BioOutsource (now part of Sartorius Stedim Biotech Group) is a leading provider of contract testing services to the global biopharmaceutical and biotechnology industries. BioOutsource was founded in 2007 and was acquired by Sartorius Stedim Biotech in 2015. We are accredited for GMP, GLP and GCP and provide contract testing services to assess the quality and safety of biologic drugs and vaccines including: A range of off-the-shelf assays for biosimilar characterisation and comparability Biosafety testing of cell banks and bulk harvest as well as cell line stability and lot release At BioOutsource we don't just perform contract testing services; we are committed to delivering service excellence, with an in-house R&D department, we are constantly adding to our existing portfolio of services to address market demands. Our innovative approach and client management model ensures projects are managed efficiently, cost-effectively and delivered on-time.
Cellca (now part of Sartorius Stedim Biotech Group) is a recognised leader in cell line and process development, specialising in protein production of biologics in mammalian cells specifically for the industrial production environment. Cellca was founded in 2005 and was acquired by Sartorius Stedim Biotech in 2015. Based on our in-depth expertise, know-how and intellectual property, Cellca has established a unique technology platform, Cellca CHO Expression Platform, which is one of the most competitive systems available.
Cellca offers the following products and services for the production of biopharmaceuticals from mammalian (CHO) cell cultures: Fee for Service: Our service is divided into work packages starting from DNA synthesis to RCB generation and additional stability studies. Technology Platform Licensing: Our technology platform is available on the basis of a yearly fee along with further success fee on mutually agreed milestone achievements.
Keywords:
Research Organisations, Scientific and Technical Services, Labs
Biooutsource Limited is listed in the following categories:

Reviews

Yably

Biooutsource Limited

4.8 from 5

Very good

6 Reviews

Yably

Reach for the stars

Be the first to write a review for Biooutsource Limited!

Share your experience!

Buy a Premium Entry
Facebook
Twitter